Bioactive substances in fresh frozen plasma (FFP) are considered to be
related to adverse reactions after transfusion, particularly in septi
c or traumatized patients. Therefore, we analysed the concentration of
various bioactive substances (histamine, eosinophil cationic protein,
eosinophil protein X, myeloperoxidase and interleukin-6) in 25 u, of
thawed FFP from healthy donors. These were compared with donor plasma
concentrations of 24 healthy controls. In addition, we analysed the co
ncentration of the bioactive substances, except interleukin-6, in 25 u
. of thawed FFP, which were subjected to leucocyte filtration before f
reezing and storage. Finally, we analysed the substances in 10 leucocy
te non-filtered plasma units before freezing and storage, and after th
awing, respectively. Before analyses, which were performed by ELISA an
d RIA methods, these latter samples were sterile filtered through a 0.
20-mu m filter. Histamine, eosinophil cationic protein, eosinophil pro
tein X and myeloperoxidase concentrations were significantly greater (
P<0.05) in the 25 u. of FFP compared with normal donor plasma. Pre-sto
rage leucocyte filtration reduced concentrations of the bioactive subs
tances in FFP to concentrations comparable with normal donor plasma co
ncentrations. Interleukin-g was undetectable in all FFP units and in 2
1 of the 24 control donors. Histamine, eosinophil cationic protein and
myeloperoxidase concentrations were significantly higher (P<0.05) in
samples collected from the 10 u, of FFP after freezing and thawing com
pared with samples collected before freezing. We conclude that fresh f
rozen plasma prepared by a conventional separation method contains var
ious leucocyte-derived bioactive substances, which may be reduced by p
re-storage leucocyte filtration.